RDIF announces major Sputnik V efficacy data from San Marino, an upcoming registration of the Sputnik M vaccine and reiterates vaccine combos are the key to fight the pandemic – ET HealthWorld

RDIF announces major Sputnik V efficacy data from San Marino, an upcoming registration of the Sputnik M vaccine and reiterates vaccine combos are the key to fight the pandemic – ET HealthWorld

The Russian Direct Investment Fund (RDIF, Russia‘s sovereign wealth fund) today announced new positive real-world…

View More RDIF announces major Sputnik V efficacy data from San Marino, an upcoming registration of the Sputnik M vaccine and reiterates vaccine combos are the key to fight the pandemic – ET HealthWorld
Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Commending the investigators from AIIMS on the BBV152 study published in Lancet Infectious Diseases, Bharat…

View More Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld
Bharat Biotech’s Covaxin demonstrates 100% efficacy against severe Covid-19 disease in Phase 3 interim analysis – ET HealthWorld

Bharat Biotech’s Covaxin demonstrates 100% efficacy against severe Covid-19 disease in Phase 3 interim analysis – ET HealthWorld

Hyderabad-based vaccine manufacturer Bharat Biotech announced second Interim results from Phase 3 trials on Wednesday.…

View More Bharat Biotech’s Covaxin demonstrates 100% efficacy against severe Covid-19 disease in Phase 3 interim analysis – ET HealthWorld
Moderna Covid vaccine efficacy falls slightly to 90% in US trial – ET HealthWorld

Moderna Covid vaccine efficacy falls slightly to 90% in US trial – ET HealthWorld

US biotech company Moderna announced Covid vaccine is 90 percent effective against all forms of…

View More Moderna Covid vaccine efficacy falls slightly to 90% in US trial – ET HealthWorld
AstraZeneca may have provided incomplete efficacy data from the latest Covid-19 trial -NIAID – ET HealthWorld

AstraZeneca may have provided incomplete efficacy data from the latest Covid-19 trial -NIAID – ET HealthWorld

British drugmaker AstraZeneca Plc may have provided an incomplete view of efficacy data on its…

View More AstraZeneca may have provided incomplete efficacy data from the latest Covid-19 trial -NIAID – ET HealthWorld
Submit Covaxin Phase 3 efficacy data before seeking nod for kids trials: SEC – ET HealthWorld

Submit Covaxin Phase 3 efficacy data before seeking nod for kids trials: SEC – ET HealthWorld

HYDERABAD: The Subject Expert Committee (SEC), which advises the Indian drug regulator Drugs Controller General…

View More Submit Covaxin Phase 3 efficacy data before seeking nod for kids trials: SEC – ET HealthWorld